Graf Akcie HCA (HCA Healthcare Inc). Diskuze k akciím HCA. Aktuální informace HCA.

Základní informace o společnosti HCA Healthcare Inc (Akcie HCA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 79.08B
Hodnota podniku (EV) 113.36B
Tržby 56.016B
EBITDA 12.264B
Zisk 4.967B
Růst v tržbách Q/Q 30.42 %
Růst v tržbách Y/Y 11.71 %
P/E (Cena vůči ziskům) 16.67
Forward P/E 0.01
EV/Sales 2.02
EV/EBITDA 9.24
EV/EBIT 14.28
PEG 1.01
Price/Sales 1.41
P/FCF 123.56
Price/Book 138.25
Účetní hodnota na akcii 1.79
Hotovost na akcii 5.60
FCF vůči ceně 0.81 %
Počet zaměstnanců 235,000
Tržba na zaměstnance 238.366k
Profit margin 7.28 %
Operating margin 15.33 %
Gross margin 37.43 %
EBIT margin 14.17 %
EBITDA margin 21.89 %
EPS - Zisk na akcii 14.81
EPS - Kvartální růst 35.29 %
EPS - Očekávaný růst příští rok 102.60 %
Return on assets 10.24 %
Return on equity -2,656.15 %
ROIC 14.51 %
ROCE 20.07 %
Dluhy/Equity 77.97
Čistý dluh/EBITDA 9.94
Current ratio 1.45
Quick Ratio 1.21
Volatilita 2.08
Beta 1.01
RSI 50.47
Cílová cena analytiků 155
Známka akcie (dle analytiků) 1.67
Insider ownership 22.47 %
Institutional ownership 73.87 %
Počet akcií 320.142M
Procento shortovaných akcií 1.44 %
Short ratio 2.48 %
Dividenda 1.78
Procentuální dividenda 0.73 %
Dividenda/Zisk 12.02 %
Obchodovaná od 2011
Země United States

Finanční výsledky akcie HCA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$51,533$51,336$46,677$43,614$41,490$39,678
Cost Of Goods Sold$8,369$8,481$7,724$7,316$6,933$6,638
Gross Profit$43,164$42,855$38,953$36,298$34,557$33,040
Research And Development Expenses------
SG&A Expenses$23,874$23,560$21,425$20,059$18,897$18,115
Other Operating Income Or Expenses$-9,253$-9,438$-8,579$-8,006$-7,442$-7,010
Operating Expenses$44,217$44,075$40,006$37,512$35,238$33,667
Operating Income$7,316$7,261$6,671$6,102$6,252$6,011
Total Non-Operating Income/Expense$-1,886$-2,017$-1,336$-1,721$-1,442$-2,054
Pre-Tax Income$5,430$5,244$5,335$4,381$4,810$3,957
Income Taxes$1,043$1,099$946$1,638$1,378$1,261
Income After Taxes$4,387$4,145$4,389$2,743$3,432$2,696
Other Income------
Income From Continuous Operations$4,387$4,145$4,389$2,743$3,432$2,696
Income From Discontinued Operations------
Net Income$3,754$3,505$3,787$2,216$2,890$2,129
EBITDA$10,067$9,887$8,980$8,264$8,252$7,950
EBIT$7,316$7,261$6,671$6,102$6,252$6,011
Basic Shares Outstanding338341347362384414
Shares Outstanding344348355372396427
Basic EPS$11.10$10.27$10.90$6.12$7.53$5.14
EPS - Earnings Per Share$10.93$10.07$10.66$5.95$7.30$4.99
# 2020 2019 2018 2017 2016 2015
Current Ratio1.41691.44331.34931.62021.55741.6737
Long-term Debt / Capital0.91421.01711.10021.17931.22071.2497
Debt/Equity Ratio10.7206-59.685-11.2478-6.6182-5.57-5.0427
Gross Margin83.759983.479483.452283.225683.2983.2703
Operating Margin14.196714.144114.291813.990915.068715.1495
EBIT Margin14.196714.144114.291813.990915.068715.1495
EBITDA Margin19.535119.259419.238618.94819.889120.0363
Pre-Tax Profit Margin10.536910.215111.429610.044911.59329.9728
Net Profit Margin7.28476.82768.11325.08096.96555.3657
Asset Turnover1.08511.13931.19051.19191.2291.2118
Inventory Turnover Ratio4.13284.58684.45964.6514.61284.6129
Receiveable Turnover7.30866.95616.87546.70887.12156.7376
Days Sales In Receivables49.941152.47253.087954.40651.253154.1732
ROE - Return On Equity151.6943-733.6283-150.4112-54.9149-60.9267-44.5915
Return On Tangible Equity-77.1544-46.921-40.3735-22.1406-27.8188-21.1004
ROA - Return On Assets9.23779.199311.19447.49610.16658.2336
ROI - Return On Investment13.022812.55615.07479.844613.444611.1364
Book Value Per Share8.5203-1.6694-8.5099-14.2677-15.2023-15.1628
Operating Cash Flow Per Share5.03742.80194.45140.29683.18671.2172
Free Cash Flow Per Share8.72720.91752.4953-0.8311.78010.4833